Amino Innovations Develops Next-Generation Peptide Patch Platform to Redefine Everyday Wellness

(TheNewswire)

Vancouver, British Columbia – TheNewswire - October 21, 2025 – Pangea Natural FoodsInc. (CSE: PNGA) (OTC: PNGAF) (“ Pangea ” or the“ Company ”), is excited to announce that its wholly ownedsubsidiary, Amino Innovations Inc. (“ Amino Innovations ”), has developed a next-generation peptide patchtechnology designed to make advanced peptide delivery as simple asapplying a Band-Aid. The new platform is designed to redefine everydaywellness through precision-engineered, needle-free delivery.

The Amino Innovations Patch utilizes bio-dissolvinglattice technology that delivers peptides effectively through theskin’s surface layers for rapid and efficient absorption withoutpain, mixing, or needles. The proprietary design achieves one-to-oneequivalence to traditional injectable dosing, eliminating the need forreconstitution, sterile handling, and dosing measurement. AminoInnovations ’ Patches arecompact, TSA-friendly, shelf-stable for up to six months, and enableconsistent peptide delivery for active individuals, travelers, andlongevity enthusiasts seeking advanced recovery and wellnesssupport.

Developed in the United States and manufactured in a cGMP-certified facility, each patch undergoesrigorous third-party testing to ensure pharmaceutical grade purity,stability, and consistency. By combining scientific precision withease of use, Amino Innovations has created a clean, compliant, andaccessible peptide solution for consumers looking to optimizeperformance and recovery without the barriers of injections.

The Company’s initial launch will include twoformulations designed to advance recovery and immune optimization. Thefirst formulation, known as the “Wolverine Stack Patch,” combinesBPC-157 and Thymosin Beta 4 (TB4), two naturally occurring peptidesrecognized for supporting healing, muscle recovery, tissueregeneration, and overall physical resilience. Alongside this, AminoInnovations will plansto introduce the TA-1 patch, formulated to helppromote immune balance and strengthen the body’s natural defensesystems.

Mr. Justin Kirkland, CSO and Co-Founder of AminoInnovations, commented, “These new formulations represent asignificant step forward in our mission to make advanced peptidescience accessible and effortless. We are focused on bringinginnovation, integrity, and accessibility to a category that is quicklyevolving from niche to mainstream. These patches are designed toempower individuals to enhance recovery, cellular health, and overallvitality in a simple, convenient, and needle-free format.”

The development of Amino Innovations’ peptide patchplatform represents a major milestone in the continued expansion intothe health and wellness sector. The Company remains committed tointroducing innovative, evidence-based products that align with itsvision of delivering clean and functional wellness solutions formodern consumers.

“The development of this patch technology and itsfurther validation via a third-party study could potentially unlock abreakthrough for the delivery of peptides and expand the totaladdressable market size in North America and globally in a major way. We look forward to providing additional updates during Q4-2025,”said Mr. Pratap Sandhu, CEO of Pangea.

About PangeaNatural Foods Inc.

Pangea Natural Foods Inc. is a North Americanmanufacturer specializing in clean-label foods and innovative wellnessproducts. Through its subsidiary Amino Innovations, the Company offersadvanced, needle-free peptide therapies that support recovery,cognitive function, and overall health.

On Behalf of the Board ofDirectors

"PratapSandhu"

Pratap Sandhu
CEO, Corporate Secretary and Director

+1 (604) 765-8069

Forward-Looking Information

This news release containsforward–looking statements and forward–looking information withinthe meaning of applicable securities laws. These statements relate tofuture events or future performance. All statements other thanstatements of historical fact may be forward–looking statements orinformation. The forward–looking statements and information arebased on certain key expectations and assumptions made by themanagement of the Company ,including Amino Innovation’s commercialization of the peptidepatches . As a result, therecan be no assurance that the acquisition or related matters will becompleted as proposed or at all. Although management of the Companybelieves that the expectations and assumptions on which suchforward-looking statements and information are based are reasonable,undue reliance should not be placed on the forward–lookingstatements and information since no assurance can be given that theywill prove to be correct.

Forward-looking statements andinformation are provided for the purpose of providing informationabout the current expectations and plans of management of the Companyrelating to the future. Readers are cautioned that reliance on suchstatements and information may not be appropriate for other purposes,such as making investment decisions. Since forward–lookingstatements and information address future events and conditions, bytheir very nature they involve inherent risks and uncertainties.Actual results could differ materially from those currentlyanticipated due to a number of factors and risks. These include, butare not limited to, the ability of the Company to complete its plannedfuture activities and anticipated business plans. Other factors mayalso adversely affect the future results or performance of theCompany, including general economic, market or business conditions,changes in the financial markets and changes in laws, regulations andpolicies affecting the Company's operations and theCompany's limited operating history. Accordingly, readers shouldnot place undue reliance on the forward–looking statements andinformation contained in this news release. Readers are cautioned thatthe foregoing list of factors is not exhaustive. The forward–looking statements and information contained in this news release aremade as of the date hereof and no undertaking is given to updatepublicly or revise any forward–looking statements or information,whether as a result of new information, future events or otherwise, unless so required byapplicable securities laws. The forward-looking statements orinformation contained in this news release are expressly qualified bythis cautionary statement.

Copyright (c) 2025 TheNewswire - All rights reserved.